OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels
Chenfei Zhou, Wen-Fei Wei, Jing Ma, et al.
Molecular Therapy (2021) Vol. 29, Iss. 4, pp. 1512-1528
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Engineered extracellular vesicles and their mimetics for cancer immunotherapy
Chunping Liu, Yichao Wang, Longmei Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 679-698
Closed Access | Times Cited: 108

The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases
Minxue Xu, Jie Ji, Dan-Dan Jin, et al.
Genes & Diseases (2022) Vol. 10, Iss. 5, pp. 1894-1907
Open Access | Times Cited: 99

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
Fangwei Wang, Hongsheng Lin, Qisheng Su, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 84

Extracellular vesicles and particles impact the systemic landscape of cancer
Serena Lucotti, Candia M. Kenific, Haiying Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 18
Open Access | Times Cited: 78

Roles of exosomes in immunotherapy for solid cancers
C. Lyu, Haifeng Sun, Zhenqiang Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 42

Exosomes: A New Pathway for Cancer Drug Resistance
Yunbin Zhong, Haibo Li, Peiwen Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 60

Exosomal RNAs: Novel Potential Biomarkers for Diseases—A Review
Jian Wang, Binglin Yue, Yongzhen Huang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2461-2461
Open Access | Times Cited: 56

STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
Mingjing Jiang, Bo Li
Cells (2022) Vol. 11, Iss. 19, pp. 3131-3131
Open Access | Times Cited: 43

Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 41

Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury
Yihua Bei, Yujiao Zhu, Jingwen Zhou, et al.
Circulation (2024) Vol. 150, Iss. 11, pp. 848-866
Closed Access | Times Cited: 16

Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis
Xiaojing Chen, Chu-Hong Guo, Zi‐Ci Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12

New roles of tumor-derived exosomes in tumor microenvironment
Shiqian Chen, Jinzhe Sun, Huan Zhou, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 151-166
Open Access | Times Cited: 12

Extracellular vesicles in tumor immunity: mechanisms and novel insights
Liwen Kuang, Lei Wu, Yongsheng Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Exosomes: a double‐edged sword in cancer immunotherapy
Jiayi Chen, Siyuan Hu, Jiayi Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1

Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications
Moritz Reese, Sameer A. Dhayat
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 50

Signal transducer and activator of transcription 3 signaling in tumor immune evasion
Luying Zhang, Kamil Kuča, You Li, et al.
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107969-107969
Closed Access | Times Cited: 48

New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies
Anup Singh Pathania, Philip Prathipati, Kishore B. Challagundla
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188624-188624
Open Access | Times Cited: 45

In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation
Wenxue Zhang, Yan Shi, Hu Li, et al.
Carbohydrate Polymers (2022) Vol. 288, pp. 119418-119418
Closed Access | Times Cited: 30

MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Pooja Bansal, et al.
Journal of Physiology and Biochemistry (2024)
Closed Access | Times Cited: 7

Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
Dandan Shi, Jiejing Tao, Shuli Man, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189207-189207
Closed Access | Times Cited: 7

Research Progress in the Application of Exosomes in Immunotherapy
Xiaofang Zhang, Donggang Xu, Yingqiu Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Mechanisms Controlling MicroRNA Expression in Tumor
Shipeng Chen, Ya Wang, Dongmei Li, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2852-2852
Open Access | Times Cited: 23

Exosomal miRNAs-mediated macrophage polarization and its potential clinical application
Ming yun Yu, Hui jie Jia, Jing Zhang, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109905-109905
Closed Access | Times Cited: 15

Page 1 - Next Page

Scroll to top